Power, Bradley
Ferreira, Carlos R.
Chen, Dong
Zein, Wadih M.
O’Brien, Kevin J.
Introne, Wendy J.
Stephen, Joshi
Gahl, William A.
Huizing, Marjan
Malicdan, May Christine V.
Adams, David R.
Gochuico, Bernadette R. http://orcid.org/0000-0003-4727-8918
Article History
Received: 11 September 2018
Accepted: 4 February 2019
First Online: 21 February 2019
Ethics approval and consent to participate
: Patients were admitted to the National Institutes of Health under protocols 76-HG-0238 (Clinical Trials number NCT00369421; Diagnosis and Treatment of Patients with Inborn Errors of Metabolism or Other Genetic Disorders), and/or 95-HG-0193 (Clinical Trials number NCT00001456; Clinical and Basic Investigations into Hermansky-Pudlak Syndrome), which were approved by the institutional review board of the National Human Genome Research Institute. Patients’ parents provided written informed consent.
: Written consent for publication was obtained from the patients’ parents at study enrollment.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.